ADVANCED CANCER THERAPEUTICS LLC has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CUI KUNYUAN, MAVUPHARMA INC and BUCK INST RES AGING.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Australia | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Tapolsky Gilles H | 14 |
#2 | Chand Pooran | 11 |
#3 | Trent John O | 3 |
#4 | Chesney Jason A | 2 |
#5 | Telang Sucheta | 2 |
#6 | Clem Brian F | 2 |
#7 | Miller Donald M | 1 |
#8 | Bates Paula J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015069906A2 | Modified dna quadruplex-forming oligonucleotides and methods of use | |
CA2868787A1 | Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic | |
WO2011103557A1 | Small molecule inhibitors of pfkfb3 and glycolytic flux and their methods of use as anti-cancer therapeutics | |
US2011257211A1 | Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics | |
US2008318888A1 | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |